CHE
Chemed Corp
NYSE: CHE · HEALTHCARE · MEDICAL CARE FACILITIES
$421.43
+2.14% today
Updated 2026-06-05
Market cap
$5.57B
P/E ratio
22.89
P/S ratio
2.19x
EPS (TTM)
$18.32
Dividend yield
0.55%
52W range
$365 – $560
Volume
0.2M
Chemed Corp (CHE) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$421.43
12-Month target
$373.47
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.1B | $2.1B | $2.3B | $2.4B | $2.5B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 22.89x (capped 25x) · Margin: 10.20%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.